Biomarkers of oxidative and nitro-oxidative stress: conventional and novel approaches

British Journal of Pharmacology

Volumn 174, Issue 12, 2017, Pages 1771-1783

  Cipak Gasparovic, Ana ^a   Zarkovic, Neven ^a   Zarkovic, Kamelija ^b   Semen, Khrystyna ^c   Kaminskyy, Danylo ^c   Yelisyeyeva, Olha ^c   Bottari, Serge P ^d,e  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^d INSTITUTE FOR ADVANCED BIOSCIENCES   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBONYL DERIVATIVE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TYROSINE; NITRIC OXIDE;

AEROBIC METABOLISM; CHEMICAL MODIFICATION; DISEASE MARKER; DISEASE SEVERITY; DISEASES; HEALTH STATUS; HEART RATE VARIABILITY; HUMAN; LIPID PEROXIDATION; MACROMOLECULE; MEDICAL RESEARCH; NITRATION; NITROSATION; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM;

ANIMALS; BIOMARKERS; HUMANS; NITRIC OXIDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES;

EID: 85014542693     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13673     Document Type: Review

References (138)

1. Abdelmegeed MA, Moon K-H, Hardwick JP, Gonzalez FJ, Song B-J (2009). Role of peroxisome proliferator-activated receptor-alpha in fasting-mediated oxidative stress. Free Radic Biol Med 47: 767–778.
2. Apaijai N, Pintana H, Chattipakorn SC, Chattipakorn N (2013). Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats. Br J Pharmacol 169: 1048–1057.
3. Aubert AE, Seps B, Beckers F (2003). Heart rate variability in athletes. Sports Med 33: 889–919.
4. Barglow KT, Knutson CG, Wishnok JS, Tannenbaum SR, Marletta MA (2011). Site-specific and redox-controlled S-nitrosation of thioredoxin. Proc Natl Acad Sci U S A 108: E600–E606.
5. Bast A, Haenen GRMM (2013). Ten misconceptions about antioxidants. Trends Pharmacol Sci 34: 430–436.
6. Bechtold E, King SB (2012). Chemical methods for the direct detection and labeling of S-nitrosothiols. Antioxid Redox Signal 17: 981–991.
7. Biesalski HK, Grune T, Tinz J, Zöllner I, Blumberg JB (2010). Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials. Nutrients 2: 929–949.
8. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2012). Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. CD007176.
9. Bjelakovic G, Nikolova D, Gluud C (2013). Antioxidant supplements to prevent mortality. JAMA 310: 1178–1179.
10. Bjelakovic G, Nikolova D, Gluud C (2014). Antioxidant supplements and mortality. Curr Opin Clin Nutr Metab Care 17: 40–44.
11. Bochkov VN, Oskolkova OV, Birukov KG, Levonen A-L, Binder CJ, Stöckl J (2010). Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal 12: 1009–1059.
12. Borovic S, Cipak A, Meinitzer A, Kejla Z, Perovic D, Waeg G et al. (2007). Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells. Redox Rep Commun Free Radic Res 12: 50–54.
13. Borovic S, Rabuzin F, Waeg G, Zarkovic N (2006). Enzyme-linked immunosorbent assay for 4-hydroxynonenal-histidine conjugates. Free Radic Res 40: 809–820.
14. Bottari SP (2015). Protein tyrosine nitration: a signaling mechanism conserved from yeast to man. Proteomics 15: 185–187.
15. Breusing N, Grune T, Andrisic L, Atalay M, Bartosz G, Biasi F et al. (2010). An inter-laboratory validation of methods of lipid peroxidation measurement in UVA-treated human plasma samples. Free Radic Res 44: 1203–1215.
16. Buelna-Chontal M, Zazueta C (2013). Redox activation of Nrf2 & NF-κB: a double end sword? Cell Signal 25: 2548–2557.
17. Buettner GR (2015). Moving free radical and redox biology ahead in the next decade(s). Free Radic Biol Med 78: 236–238.
18. Burmester T, Gerlach F, Hankeln T (2007). Regulation and role of neuroglobin and cytoglobin under hypoxia. Adv Exp Med Biol 618: 169–180.
19. Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC (1997). Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 23: 361–366.
20. Cadenas E, Sies H (1985). Oxidative stress: excited oxygen species and enzyme activity. Adv Enzyme Regul 23: 217–237.
21. Calabrese EJ, Iavicoli I, Calabrese V (2013). Hormesis: its impact on medicine and health. Hum Exp Toxicol 32: 120–152.
22. Cantó C, Auwerx J (2009). Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metab 20: 325–331.
23. Casas AI, Dao VT-V, Daiber A, Maghzal GJ, Di Lisa F, Kaludercic N et al. (2015). Reactive oxygen-related diseases: therapeutic targets and emerging clinical indications. Antioxid Redox Signal 23: 1171–1185.
24. Ceriello A (2002). Nitrotyrosine: new findings as a marker of postprandial oxidative stress. Int J Clin Pract Suppl 129: 51–58.
25. Chen X, Chen H, Deng R, Shen J (2014). Pros and cons of current approaches for detecting peroxynitrite and their applications. Biomed J 37: 120–126.
26. Christensen JH (2011). Omega-3 polyunsaturated fatty acids and heart rate variability. Front Physiol 2: 84.
27. Crow JP, Beckman JS, McCord JM (1995). Sensitivity of the essential zinc-thiolate moiety of yeast alcohol dehydrogenase to hypochlorite and peroxynitrite. Biochemistry 34: 3544–3552.
28. Csala M, Kardon T, Legeza B, Lizák B, Mandl J, Margittai É et al. (2015). On the role of 4-hydroxynonenal in health and disease. Biochim Biophys Acta 1852: 826–838.
29. Csibi A, Communi D, Müller N, Bottari SP (2010). Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms. PLoS One 5: e10070.
30. Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA (2003). Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol 23: 7198–7209.
31. Daiber A, Frein D, Namgaladze D, Ullrich V (2002). Oxidation and nitrosation in the nitrogen monoxide/superoxide system. J Biol Chem 277: 11882–11888.
32. Daiber A, Steven S, Weber A, Shuvaev VV, Muzykantov VR, Laher I et al. (2016). Targeting vascular (endothelial) dysfunction. Br J Pharmacol. doi:10.1111/bph.13517.
33. Das UN (2008). Do polyunsaturated fatty acids behave like an endogenous ‘polypill’? Med Hypotheses 70: 430–434.
34. Dean RT, Fu S, Stocker R, Davies MJ (1997). Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 324 (Pt 1): 1–18.
35. Dehne N, Brüne B (2014). Sensors, transmitters, and targets in mitochondrial oxygen shortage-a hypoxia-inducible factor relay story. Antioxid Redox Signal 20: 339–352.
36. Dennery PA (2010). Oxidative stress in development: nature or nurture? Free Radic. Biol Med 49: 1147–1151.
37. deRojas-Walker T, Tamir S, Ji H, Wishnok JS, Tannenbaum SR (1995). Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem Res Toxicol 8: 473–477.
38. Esterbauer H, Schaur RJ, Zollner H (1991). Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81–128.
39. Flögel U, Fago A, Rassaf T (2010). Keeping the heart in balance: the functional interactions of myoglobin with nitrogen oxides. J Exp Biol 213: 2726–2733.
40. Forman HJ, Davies KJA, Ursini F (2014). How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radic Biol Med 66: 24–35.
41. Frein D, Schildknecht S, Bachschmid M, Ullrich V (2005). Redox regulation: a new challenge for pharmacology. Biochem Pharmacol 70: 811–823.
42. Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D et al. (2015). Clinical relevance of biomarkers of oxidative stress. Antioxid Redox Signal 23: 1144–1170.
43. Gasparovic AC, Jaganjac M, Mihaljevic B, Sunjic SB, Zarkovic N (2013). Assays for the measurement of lipid peroxidation. Methods Mol Biol 965: 283–296.
44. Goszcz K, Deakin SJ, Duthie GG, Stewart D, Leslie SJ, Megson IL (2015). Antioxidants in Cardiovascular Therapy: Panacea or False Hope? Front Cardiovasc Med 2: 29.
45. Groenendaal F, Lammers H, Smit D, Nikkels PGJ (2006). Nitrotyrosine in brain tissue of neonates after perinatal asphyxia. Arch Dis Child Fetal Neonatal Ed 91: F429–F433.
46. Groenendaal F, Vles J, Lammers H, Vente JD, Smit D, Nikkels PGJ (2008). Nitrotyrosine in human neonatal spinal cord after perinatal asphyxia. Neonatology 93: 1–6.
47. Gueraud F, Atalay M, Bresgen N, Cipak A, Eckl PM, Huc L et al. (2010). Chemistry and biochemistry of lipid peroxidation products. Free Radic Res 44: 1098–1124.
48. Guéraud F, Taché S, Steghens J-P, Milkovic L, Borovic-Sunjic S, Zarkovic N et al. (2015). Dietary polyunsaturated fatty acids and heme iron induce oxidative stress biomarkers and a cancer promoting environment in the colon of rats. Free Radic Biol Med 83: 192–200.
49. Hayes JD, Dinkova-Kostova AT (2014). The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 39: 199–218.
50. Hoehn T, Janssen S, Mani AR, Brauers G, Moore KP, Schadewaldt P et al. (2008). Urinary excretion of the nitrotyrosine metabolite 3-nitro-4-hydroxyphenylacetic acid in preterm and term infants. Neonatology 93: 73–76.
51. Holzerová E, Prokisch H (2015). Mitochondria: much ado about nothing? How dangerous is reactive oxygen species production? Int J Biochem Cell Biol 63: 16–20.
52. Hybertson BM, Gao B, Bose SK, McCord JM (2011). Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol Aspects Med 32: 234–246.
53. Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, Snyder SH (2001). Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol 3: 193–197.
54. Jankovic A, Korac A, Buzadzic B, Otasevic V, Stancic A, Daiber A et al. (2015). Redox implications in adipose tissue (dys)function – A new look at old acquaintances. Redox Biol 6: 19–32.
55. Jankovic A, Korac A, Buzadzic B, Stancic A, Otasevic V, Ferdinandy P et al. (2016). Targeting the nitric oxide/superoxide ratio in adipose tissue: relevance in obesity and diabetes management. Br J Pharmacol. doi:10.1111/bph.13498.
56. Jaramillo MC, Zhang DD (2013). The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev 27: 2179–2191.
57. Jarczok MN, Kleber ME, Koenig J, Loerbroks A, Herr RM, Hoffmann K et al. (2015). Investigating the associations of self-rated health: heart rate variability is more strongly associated than inflammatory and other frequently used biomarkers in a cross sectional occupational sample. PLoS One 10: e0117196.
58. Jezek P, Hlavatá L (2005). Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 37: 2478–2503.
59. Jiao K, Mandapati S, Skipper PL, Tannenbaum SR, Wishnok JS (2001). Site-selective nitration of tyrosine in human serum albumin by peroxynitrite. Anal Biochem 293: 43–52.
60. Karimi Galougahi K, Antoniades C, Nicholls SJ, Channon KM, Figtree GA (2015). Redox biomarkers in cardiovascular medicine. Eur Heart J 36: 1576–1582, 1582a-b.
61. Kohn HI, Liversedge M (1944). On a new aerobic metabolite whose production by brain is inhibited by apomorphine, emetine, ergotamine, epinephrine, and menadione. J Pharmacol Exp Ther 82: 292–300.
62. Kondrashov FA, Koonin EV, Morgunov IG, Finogenova TV, Kondrashova MN (2006). Evolution of glyoxylate cycle enzymes in Metazoa: evidence of multiple horizontal transfer events and pseudogene formation. Biol Direct 1: 31.
63. Kossmann S, Hu H, Steven S, Schönfelder T, Fraccarollo D, Mikhed Y et al. (2014). Inflammatory monocytes determine endothelial nitric-oxide synthase uncoupling and nitro-oxidative stress induced by angiotensin II. J Biol Chem 289: 27540–27550.
64. Kowaltowski AJ, de Souza-Pinto NC, Castilho RF, Vercesi AE (2009). Mitochondria and reactive oxygen species. Free Radic Biol Med 47: 333–343.
65. Kuwano T, Watanabe M, Kagawa D, Murase T (2015). hydrolyzed methylhesperidin induces antioxidant enzyme expression via the Nrf2-ARE pathway in normal human epidermal keratinocytes. J Agric Food Chem 63: 7937–7944.
66. Lahiri MK, Kannankeril PJ, Goldberger JJ (2008). Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. J Am Coll Cardiol 51: 1725–1733.
67. Lahiri S, Roy A, Baby SM, Hoshi T, Semenza GL, Prabhakar NR (2006). Oxygen sensing in the body. Prog Biophys Mol Biol 91: 249–286.
68. LaRovere MT, Christensen JH (2015). The autonomic nervous system and cardiovascular disease: role of n-3 PUFAs. Vascul Pharmacol 71: 1–10.
69. Levonen A-L, Hill BG, Kansanen E, Zhang J, Darley-Usmar VM (2014). Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics. Free Radic Biol Med 71: 196–207.
70. Linnane AW, Eastwood H (2006). Cellular redox regulation and prooxidant signaling systems: a new perspective on the free radical theory of aging. Ann N Y Acad Sci 1067: 47–55.
71. Lundberg JO, Weitzberg E, Cole JA, Benjamin N (2004). Nitrate, bacteria and human health. Nat Rev Microbiol 2: 593–602.
72. Malik M, Bigger JT, Camm AJ, Kleiger RE, Malliani A, Moss AJ et al. (1996). Guidelines heart rate variability standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17: 354–381.
73. Mani AR, Pannala AS, Orie NN, Ollosson R, Harry D, Rice-Evans CA et al. (2003). Nitration of endogenous para-hydroxyphenylacetic acid and the metabolism of nitrotyrosine. Biochem J 374: 521–527.
74. McMahon M, Lamont DJ, Beattie KA, Hayes JD (2010). Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc Natl Acad Sci U S A 107: 18838–18843.
75. Mikhed Y, Bruns K, Schildknecht S, Jörg M, Dib M, Oelze M et al. (2016). Formation of 2-nitrophenol from salicylaldehyde as a suitable test for low peroxynitrite fluxes. Redox Biol 7: 39–47.
76. Milkovic L, Cipak Gasparovic A, Zarkovic N (2015). Overview on major lipid peroxidation bioactive factor 4-hydroxynonenal as pluripotent growth-regulating factor. Free Radic Res 49: 850–860.
77. Mrakovcic L, Cindric M, Zarkovic N, Sunjic, SB, Milankovic AM, Wildburger R (2010). In vitro model of bone regeneration with bioactive glass and lipid peroxidation. CEMED 4: 73–78.
78. Murakami S, Motohashi H (2015). Roles of Nrf2 in cell proliferation and differentiation. Free Radic Biol Med 88: 168–178.
79. Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R et al. (2010). Pathological aspects of lipid peroxidation. Free Radic Res 44: 1125–1171.
80. Nuriel T, Hansler A, Gross SS (2011). Protein nitrotryptophan: formation, significance and identification. J Proteomics 74: 2300–2312.
81. Ochi H, Takeda S (2015). The Two Sides of Vitamin E Supplementation. Gerontology 61: 319–326.
82. Ohshima H, Friesen M, Brouet I, Bartsch H (1990). Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins. Food Chem Toxicol 28: 647–652.
83. Paolini M, Abdel-Rahman SZ, Sapone A, Pedulli GF, Perocco P, Cantelli-Forti G et al. (2003). β-Carotene: a cancer chemopreventive agent or a co-carcinogen? Mutat Res 543: 195–200.
84. Piroddi M, Palmese A, Pilolli F, Amoresano A, Pucci P, Ronco C et al. (2011). Plasma nitroproteome of kidney disease patients. Amino Acids 40: 653–667.
85. Prabhakar NR, Kumar GK, Nanduri J, Semenza GL (2007). ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. Antioxid Redox Signal 9: 1397–1403.
86. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB (2010). Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol Med 49: 1603–1616.
87. Rio RD, Moya EA, Iturriaga R (2010). Carotid body and cardiorespiratory alterations in intermittent hypoxia: the oxidative link. Eur Respir J 36: 143–150.
88. Ristow M, Zarse K (2010). How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis). Exp Gerontol 45: 410–418.
89. Rocha BS, Gago B, Barbosa RM, Lundberg JO, Radi R, Laranjinha J (2012). Intragastric nitration by dietary nitrite: implications for modulation of protein and lipid signaling. Free Radic Biol Med 52: 693–698.
90. Ryberg H, Caidahl K (2007). Chromatographic and mass spectrometric methods for quantitative determination of 3-nitrotyrosine in biological samples and their application to human samples. J Chromatogr B Analyt Technol Biomed Life Sci 851: 160–171.
91. Sarsour EH, Kumar MG, Chaudhuri L, Kalen AL, Goswami PC (2009). Redox control of the cell cycle in health and disease. Antioxid Redox Signal 11: 2985–3011.
92. Satoh T, McKercher SR, Lipton SA (2014). Reprint of: Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. Free Radic Biol Med 66: 45–57.
93. Schmidt HHHW, Stocker R, Vollbracht C, Paulsen G, Riley D, Daiber A et al. (2015). Antioxidants in Translational Medicine. Antioxid Redox Signal 23: 1130–1143.
94. Schönfeld P, Schlüter T, Fischer K-D, Reiser G (2011). Non-esterified polyunsaturated fatty acids distinctly modulate the mitochondrial and cellular ROS production in normoxia and hypoxia. J Neurochem 118: 69–78.
95. Schulz E, Jansen T, Wenzel P, Daiber A, Münzel T (2008). Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 10: 1115–1126.
96. Schulz E, Wenzel P, Münzel T, Daiber A (2014). Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress. Antioxid Redox Signal 20: 308–324.
97. Semen K, Yelisyeyeva O, Jarocka-Karpowicz I, Kaminskyy D, Solovey L, Skrzydlewska E et al. (2016). Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variability. Redox Biol 7: 48–57.
98. Semen KO, Yelisyeyeva OP, Kaminskyy DV, Cherkas AP, Zarkovic K, Lutsyk O et al. (2010). Interval hypoxic training in complex treatment of Helicobacter pylori-associated peptic ulcer disease. Acta Biochim Pol 57: 199–208.
99. Semen KO, Yelisyeyeva OP, Іlenkiv NV, Kaminskyy DV, Savka NO, Yavorsky OH (2013). Condition of the pro−/antioxidant system and heart rate variability in subjects from various functional groups. Medytsyna Transp Ukr 3: 34–41.
100. Semenza GL (2011). Oxygen sensing, homeostasis, and disease. N Engl J Med 365: 537–547.
101. Sies H, Cadenas E (1985). Oxidative stress: damage to intact cells and organs. Philos Trans R Soc Lond B Biol Sci 311: 617–631.
102. Sinha V, Wijewickrama GT, Chandrasena REP, Xu H, Edirisinghe PD, Schiefer IT et al. (2010). Proteomic and mass spectroscopic quantitation of protein S-nitrosation differentiates NO-donors. ACS Chem Biol 5: 667–680.
103. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP et al. (2016). The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 44: D1054–D1068.
104. Spickett CM, Pitt AR (2015). Oxidative lipidomics coming of age: advances in analysis of oxidized phospholipids in physiology and pathology. Antioxid Redox Signal 22: 1646–1666.
105. Spickett CM, Wiswedel I, Siems W, Zarkovic K, Zarkovic N (2010). Advances in methods for the determination of biologically relevant lipid peroxidation products. Free Radic Res 44: 1172–1202.
106. Spiteller G (1998). Linoleic acid peroxidation--the dominant lipid peroxidation process in low density lipoprotein--and its relationship to chronic diseases. Chem Phys Lipids 95: 105–162.
107. Supakul L, Pintana H, Apaijai N, Chattipakorn S, Shinlapawittayatorn K, Chattipakorn N (2014). Protective effects of garlic extract on cardiac function, heart rate variability, and cardiac mitochondria in obese insulin-resistant rats. Eur J Nutr 53: 919–928.
108. Swaim MW, Pizzo SV (1988). Methionine sulfoxide and the oxidative regulation of plasma proteinase inhibitors. J Leukoc Biol 43: 365–379.
109. Thomas DD (2015). Breathing new life into nitric oxide signaling: a brief overview of the interplay between oxygen and nitric oxide. Redox Biol 5: 225–233.
110. Thomas DD, Heinecke JL, Ridnour LA, Cheng RY, Kesarwala AH, Switzer CH et al. (2015). Signaling and stress: The redox landscape in NOS2 biology. Free Radic Biol Med 87: 204–225.
111. Trujillo M, Radi R (2002). Peroxynitrite reaction with the reduced and the oxidized forms of lipoic acid: new insights into the reaction of peroxynitrite with thiols. Arch Biochem Biophys 397: 91–98.
112. Tsikas D, Duncan MW (2014). Mass spectrometry and 3-nitrotyrosine: strategies, controversies, and our current perspective. Mass Spectrom Rev 33: 237–276.
113. Ullrich V, Kissner R (2006). Redox signaling: bioinorganic chemistry at its best. J Inorg Biochem 100: 2079–2086.
114. Vainio H (2000). Chemoprevention of cancer: lessons to be learned from beta-carotene trials. Toxicol Lett 112: 513–517.
115. Vaiserman AM (2010). Hormesis, adaptive epigenetic reorganization, and implications for human health and longevity. Dose Response 8: 16–21.
116. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39: 44–84.
117. Verdin E, Hirschey MD, Finley LWS, Haigis MC (2010). Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 35: 669–675.
118. Viner RI, Williams TD, Schöneich C (1999). Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase. Biochemistry 38: 12408–12415.
119. Violi F, Pignatelli P (2015). Clinical application of NOX activity and other oxidative biomarkers in cardiovascular disease: a critical review. Antioxid Redox Signal 23: 514–532.
120. Vistoli G, Maddis DD, Cipak A, Zarkovic N, Carini M, Aldini G (2013). Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res 47 (Suppl 1): 3–27.
121. Vladykovskaya E, Sithu SD, Haberzettl P, Wickramasinghe NS, Merchant ML, Hill BG et al. (2012). Lipid peroxidation product 4-hydroxy-trans-2-nonenal causes endothelial activation by inducing endoplasmic reticulum stress. J Biol Chem 287: 11398–11409.
122. Voeikov VL (2005). Biological oxidation: over a century of hardship for the concept of active oxygen. Cell Mol Biol (Noisy-le-Grand) 51: 663–675.
123. Vollaard NBJ, Reeder BJ, Shearman JP, Menu P, Wilson MT, Cooper CE (2005). A new sensitive assay reveals that hemoglobin is oxidatively modified in vivo. Free Radic Biol Med 39: 1216–1228.
124. Vrolijk MF, Opperhuizen A, Jansen EHJM, Godschalk RW, Schooten FJ Van, Bast A et al. (2015). The shifting perception on antioxidants: the case of vitamin E and β-carotene. Redox Biol 4: 272–278.
125. Wakita C, Honda K, Shibata T, Akagawa M, Uchida K (2011). A method for detection of 4-hydroxy-2-nonenal adducts in proteins. Free Radic Biol Med 51: 1–4.
126. Ward JPT (2008). Oxygen sensors in context. Biochim Biophys Acta 1777: 1–14.
127. Wayenberg J-L, Cavedon C, Ghaddhab C, Lefèvre N, Bottari SP (2011). Early transient hypoglycemia is associated with increased albumin nitration in the preterm infant. Neonatology 100: 387–397.
128. Wayenberg J-L, Ransy V, Vermeylen D, Damis E, Bottari SP (2009). Nitrated plasma albumin as a marker of nitrative stress and neonatal encephalopathy in perinatal asphyxia. Free Radic Biol Med 47: 975–982.
129. Weber D, Milkovic L, Bennett SJ, Griffiths HR, Zarkovic N, Grune T (2013). Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies. Redox Biol 1: 226–233.
130. Widmer CC, Pereira CP, Gehrig P, Vallelian F, Schoedon G, Buehler PW et al. (2010). Hemoglobin can attenuate hydrogen peroxide-induced oxidative stress by acting as an antioxidative peroxidase. Antioxid Redox Signal 12: 185–198.
131. Wolkow CA, Iser WB (2006). Uncoupling protein homologs may provide a link between mitochondria, metabolism and lifespan. Ageing Res Rev 5: 196–208.
132. Woolley JF, Stanicka J, Cotter TG (2013). Recent advances in reactive oxygen species measurement in biological systems. Trends Biochem Sci 38: 556–565.
133. Yelisyeyeva O, Semen K, Zarkovic N, Kaminskyy D, Lutsyk O, Rybalchenko V (2012). Activation of aerobic metabolism by Amaranth oil improves heart rate variability both in athletes and patients with type 2 diabetes mellitus. Arch Physiol Biochem 118: 47–57.
134. Yelisyeyeva OP, Semen KO, Ostrovska GV, Kaminskyy DV, Sirota TV, Zarkovic N et al. (2014). The effect of Amaranth oil on monolayers of artificial lipids and hepatocyte plasma membranes with adrenalin-induced stress. Food Chem 147: 152–159.
135. Zakharchenko MV, Zakharchenko AV, Khunderyakova NV, Tutukina MN, Simonova MA, Vasilieva AA et al. (2013). Burst of succinate dehydrogenase and α-ketoglutarate dehydrogenase activity in concert with the expression of genes coding for respiratory chain proteins underlies short-term beneficial physiological stress in mitochondria. Int J Biochem Cell Biol 45: 190–200.
136. Zarkovic K, Larroque-Cardoso P, Pucelle M, Salvayre R, Waeg G, Nègre-Salvayre A et al. (2015). Elastin aging and lipid oxidation products in human aorta. Redox Biol 4: 109–117.
137. Zarkovic N (2003). 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 24: 281–291.
138. Zarkovic N, Ilic Z, Jurin M, Schaur RJ, Puhl H, Esterbauer H (1993). Stimulation of HeLa cell growth by physiological concentrations of 4-hydroxynonenal. Cell Biochem Funct 11: 279–286.